These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 15939682)
21. Plasma coagulation profiles in patients with severe primary pulmonary hypertension. Hoeper MM; Sosada M; Fabel H Eur Respir J; 1998 Dec; 12(6):1446-9. PubMed ID: 9877507 [TBL] [Abstract][Full Text] [Related]
22. Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation. Binotto MA; Maeda NY; Lopes AA Cardiol Young; 2005 Feb; 15(1):26-30. PubMed ID: 15831157 [TBL] [Abstract][Full Text] [Related]
23. [Haemostatic and fibrinolytic variables in women with anorexia nervosa]. Sobieszczańska S; Rabe-Jabłońska J Psychiatr Pol; 2005; 39(4):741-59. PubMed ID: 16237979 [TBL] [Abstract][Full Text] [Related]
24. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke. Zhao L; Gray L; Leonardi-Bee J; Weaver CS; Heptinstall S; Bath PM Platelets; 2006 Mar; 17(2):100-4. PubMed ID: 16421011 [TBL] [Abstract][Full Text] [Related]
26. [Assessment of variables relative to prethrombotic state after operation in patients with gynecological malignancies]. Liu BY; Zhong M; Yu YH; Li JS; Zheng L; Wang Q Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):84-6. PubMed ID: 12527529 [TBL] [Abstract][Full Text] [Related]
27. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease. Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383 [TBL] [Abstract][Full Text] [Related]
28. Maternal and cord blood hemostasis at delivery. Schneider DM; von Tempelhoff GF; Herrle B; Heilmann L J Perinat Med; 1997; 25(1):55-61. PubMed ID: 9085204 [TBL] [Abstract][Full Text] [Related]
29. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome. Ragab A; Abousamra NK; Higazy A; Saleh O Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313 [TBL] [Abstract][Full Text] [Related]
30. [Effects of hydrogen sulfide on vascular inflammation in pulmonary hypertension induced by high pulmonary blood flow: experiment with rats]. Jin HF; Liang C; Liang JM; Tang CS; DU JB Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2235-9. PubMed ID: 19087668 [TBL] [Abstract][Full Text] [Related]
31. Fibrinolytic system in normotensive subjects and hypertensive patients. Armas-Hernández MJ; Hernández-Hernández R; Armas-Padilla MC; Sosa-Canache B; Cammarata R; Pacheco B; Guerrero-Pajuelo J; Israili ZH; Valasco M Am J Ther; 2007; 14(2):177-82. PubMed ID: 17414587 [TBL] [Abstract][Full Text] [Related]
33. [Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC)]. Takahashi H; Hanano M; Takizawa S; Tatewaki W; Fuse I; Satoh K; Wada K; Shibata A Rinsho Ketsueki; 1988 Mar; 29(3):336-43. PubMed ID: 3260969 [No Abstract] [Full Text] [Related]
34. Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Peled N; Shitrit D; Bendayan D; Peled E; Kramer MR Respiration; 2007; 74(1):50-5. PubMed ID: 16954652 [TBL] [Abstract][Full Text] [Related]
35. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837 [TBL] [Abstract][Full Text] [Related]
36. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis]. Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960 [TBL] [Abstract][Full Text] [Related]
37. [Changes of pulmonary artery structural remodeling in pulmonary hypertension induced by high pulmonary flow in rats]. Li XH; Du JB; Tang XY; Jin HF; Tang CS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):446-51. PubMed ID: 16178437 [TBL] [Abstract][Full Text] [Related]
38. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers. Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312 [TBL] [Abstract][Full Text] [Related]
39. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients. Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053 [TBL] [Abstract][Full Text] [Related]
40. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Amabile N; Heiss C; Real WM; Minasi P; McGlothlin D; Rame EJ; Grossman W; De Marco T; Yeghiazarians Y Am J Respir Crit Care Med; 2008 Jun; 177(11):1268-75. PubMed ID: 18310479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]